Kang YN - Search Results

1

Locoregional Recurrence Prediction Using a Deep Neural Network of Radiological and Radiotherapy Images.

Han K, Joung JF, Han M, Sung W, Kang YN. Han K, et al. Among authors: kang yn. J Pers Med. 2022 Jan 21;12(2):143. doi: 10.3390/jpm12020143. J Pers Med. 2022. PMID: 35207631 Free PMC article.

2

Predicting vertebral compression fracture prior to spinal SBRT using radiomics from planning CT.

Seol Y, Song JH, Choi KH, Lee YK, Choi BO, Kang YN. Seol Y, et al. Among authors: kang yn. Eur Spine J. 2023 Oct 9. doi: 10.1007/s00586-023-07963-3. Online ahead of print. Eur Spine J. 2023. PMID: 37814013

3

Medical X-band linear accelerator for high-precision radiotherapy.

Lee YS, Kim S, Kim GJ, Lee JH, Kim IS, Kim JI, Shin KY, Seol Y, Oh T, An NY, Lee J, Hwang J, Oh Y, Kang YN. Lee YS, et al. Among authors: kang yn. Med Phys. 2021 Sep;48(9):5327-5342. doi: 10.1002/mp.15077. Epub 2021 Jul 28. Med Phys. 2021. PMID: 34224166

4

Stereotactic body radiotherapy for patients with unresectable primary hepatocellular carcinoma: dose-volumetric parameters predicting the hepatic complication.

Son SH, Choi BO, Ryu MR, Kang YN, Jang JS, Bae SH, Yoon SK, Choi IB, Kang KM, Jang HS. Son SH, et al. Among authors: kang yn, kang km. Int J Radiat Oncol Biol Phys. 2010 Nov 15;78(4):1073-80. doi: 10.1016/j.ijrobp.2009.09.009. Epub 2010 Mar 6. Int J Radiat Oncol Biol Phys. 2010. PMID: 20207492

5

Long-term clinical experience of high-dose ablative lung radiotherapy: high pre-treatment [18F]fluorodeoxyglucose-positron emission tomography maximal standardized uptake value of the primary tumor adversely affects treatment outcome.

Lee DS, Kim YS, Yoo IeR, Kang YN, Kim SJ, Oh JK, Kim YK, Wang YP, Park JG, Kang JH, Han DH, Ahn MI, Lee KY. Lee DS, et al. Among authors: kang jh, kang yn. Lung Cancer. 2013 May;80(2):172-8. doi: 10.1016/j.lungcan.2012.12.023. Epub 2013 Feb 8. Lung Cancer. 2013. PMID: 23489556

6

Kim SW, Shin HJ, Hwang JH, Shin JS, Park SK, Kim JY, Kim KJ, Kay CS, Kang YN. Kim SW, et al. Among authors: kang yn. PLoS One. 2017 Sep 19;12(9):e0185082. doi: 10.1371/journal.pone.0185082. eCollection 2017. PLoS One. 2017. PMID: 28926610 Free PMC article.

7

Dosimetric comparison between modulated arc therapy and static intensity modulated radiotherapy in thoracic esophageal cancer: a single institutional experience.

Choi KH, Kim J, Lee SW, Kang YN, Jang H. Choi KH, et al. Among authors: kang yn. Radiat Oncol J. 2018 Mar;36(1):63-70. doi: 10.3857/roj.2017.00241. Epub 2017 Dec 23. Radiat Oncol J. 2018. PMID: 29262672 Free PMC article.

8

Verification of lithium formate monohydrate in 3D-printed container for electron paramagnetic resonance dosimetry in radiotherapy.

Shin JS, Choi H, Shin HJ, Kim SW, Park HW, Kim J, Kim A, Hwang J, Seol Y, Oh T, Jang HS, Choi BO, Kang YN. Shin JS, et al. Among authors: kang yn. Australas Phys Eng Sci Med. 2019 Sep;42(3):811-818. doi: 10.1007/s13246-019-00786-x. Epub 2019 Aug 13. Australas Phys Eng Sci Med. 2019. PMID: 31410839

9

[No title available]

[No authors listed] [No authors listed] PMID: 34701150

10

Fractionated stereotactic radiotherapy in patients with primary hepatocellular carcinoma.

Choi BO, Jang HS, Kang KM, Lee SW, Kang YN, Chai GY, Choi IB. Choi BO, et al. Among authors: kang yn, kang km. Jpn J Clin Oncol. 2006 Mar;36(3):154-8. doi: 10.1093/jjco/hyi236. Epub 2006 Mar 6. Jpn J Clin Oncol. 2006. PMID: 16520355

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

271 results

Search Page